In patients with left ventricular assist devices, the presence of aortic root thrombosis did not significantly impact the incidence of composite adverse events (p=0.276) or mortality (p=0.814).
Cohort (n=44)
No
Does the development of aortic root thrombosis impact composite adverse events or mortality in adult patients with left ventricular assist devices?
Aortic root thrombosis is frequently detected by echocardiography in LVAD patients (45%) but does not appear to significantly increase the risk of mortality or composite thromboembolic events during mid-term follow-up.
p-value: p=0.276
ART may be under-recognized in LVAD patients, potentially leading to cardiac and end-organ damage. While ART does not significantly impact mortality, it emphasizes the need for careful management of LVAD patients.
Karahan et al. (Thu,) conducted a cohort in End-stage heart failure with LVAD (n=44). Aortic root thrombosis (ART) vs. No aortic root thrombosis was evaluated on Composite outcome (cerebrovascular events, pump thrombosis, myocardial infarction, or embolic events) (p=0.276). In patients with left ventricular assist devices, the presence of aortic root thrombosis did not significantly impact the incidence of composite adverse events (p=0.276) or mortality (p=0.814).